One of the unique challenges affecting the development of new vaccines and therapeutics against pathogens with pandemic potential is the complexity of a global regulatory process. Companies and regulators, working closely with the WHO and CEPI, have deployed strategies to design clinical trials and create pathways tailored to these products, all while responding to ongoing outbreaks all over the world. This panel will focus on the unique issues of clinical and regulatory decision-making and approvals for vaccines and drugs for use in outbreak settings. Using Ebola and Lassa Fever as case studies, panelists will discuss key learnings from the current and past global responses and share how the global health community can work together to speed up our overall response in emergency situations.
Session ID: 545492